BIO NOTEBOOK: Janssen's R&D chief Hait makes no little plans
This article was originally published in Scrip
William Hait, Janssen’s global head of R&D and an oncologist, aims high. Very high. Asked his goal for the Johnson & Johnson company’s cancer-drug business, Dr Hait told his bosses that he wanted to make it the top program in the world.